Google DeepMind and Meta have joined a virtual biology initiative valued at $300 million, according to a Techub News brief citing Crypto Briefing. The investment is aimed at using artificial intelligence and related technologies to speed up drug development. The stated goal is to cut a process that can take decades down to five years. The announcement links two major AI players to a healthcare-focused effort centered on shortening research and development timelines.
Google DeepMind and Meta have joined a $300 million virtual biology initiative, according to a Techub News brief citing Crypto Briefing.
The investment is intended to use AI and related technologies to accelerate drug development. The effort aims to shorten a development cycle that can take decades to five years.
This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan. Disclaimer:
The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.
Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.
